A. Hvidberg

437 total citations
11 papers, 338 citations indexed

About

A. Hvidberg is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, A. Hvidberg has authored 11 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in A. Hvidberg's work include Pancreatic function and diabetes (5 papers), Diabetes Treatment and Management (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). A. Hvidberg is often cited by papers focused on Pancreatic function and diabetes (5 papers), Diabetes Treatment and Management (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). A. Hvidberg collaborates with scholars based in Denmark. A. Hvidberg's co-authors include J. Hilsted, Michael Højby Rasmussen, Anders Juul, Katharina M. Main, Anders Gotfredsen, N E Skakkebæk, R. Djurup, Sten Madsbad, Thure Krarup and Jens J. Holst and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetologia and British Journal of Clinical Pharmacology.

In The Last Decade

A. Hvidberg

11 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hvidberg Denmark 7 221 108 88 67 63 11 338
Z. Chap United States 10 224 1.0× 114 1.1× 84 1.0× 20 0.3× 37 0.6× 23 404
K. Goitom Germany 7 96 0.4× 97 0.9× 63 0.7× 32 0.5× 25 0.4× 7 306
David Y. Cheng United States 13 82 0.4× 92 0.9× 162 1.8× 92 1.4× 32 0.5× 18 379
S. E. Oleandri Italy 11 255 1.2× 88 0.8× 76 0.9× 28 0.4× 78 1.2× 25 330
Federica Costantino Italy 9 147 0.7× 176 1.6× 81 0.9× 93 1.4× 60 1.0× 9 424
Kazue Endo Japan 7 143 0.6× 123 1.1× 136 1.5× 87 1.3× 36 0.6× 13 396
M Löbig Germany 11 137 0.6× 103 1.0× 86 1.0× 51 0.8× 77 1.2× 17 364
Martin J. Conway United States 11 185 0.8× 105 1.0× 111 1.3× 33 0.5× 50 0.8× 17 377
Andreas Pfeiffer Germany 6 149 0.7× 90 0.8× 55 0.6× 69 1.0× 86 1.4× 17 443
Jan Lynge Denmark 6 346 1.6× 94 0.9× 197 2.2× 31 0.5× 22 0.3× 6 547

Countries citing papers authored by A. Hvidberg

Since Specialization
Citations

This map shows the geographic impact of A. Hvidberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hvidberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hvidberg more than expected).

Fields of papers citing papers by A. Hvidberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hvidberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hvidberg. The network helps show where A. Hvidberg may publish in the future.

Co-authorship network of co-authors of A. Hvidberg

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hvidberg. A scholar is included among the top collaborators of A. Hvidberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hvidberg. A. Hvidberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hvidberg, A., A. Rosenfalck, Niels Juel Christensen, & J. Hilsted. (1998). Long‐term administration of theophylline and glucose recovery after hypoglycaemia in patients with Type 1 diabetes mellitus. Diabetic Medicine. 15(7). 608–614. 6 indexed citations
2.
Hvidberg, A., A. Rosenfalck, Niels Juel Christensen, & J. Hilsted. (1998). Long‐term administration of theophylline and glucose recovery after hypoglycaemia in patients with Type 1 diabetes mellitus. Diabetic Medicine. 15(7). 608–614. 1 indexed citations
3.
Dejgaard, A., Peter Andersen, A. Hvidberg, & J. Hilsted. (1996). Cardiovascular, Metabolic, and Hormonal Responses to Noradrenaline in Diabetic Patients with Autonomic Neuropathy. Diabetic Medicine. 13(11). 983–989. 7 indexed citations
4.
Toft-Nielsen, M., A. Hvidberg, J. Hilsted, H Dige‐Petersen, & Jens J. Holst. (1996). No Effect of Beta-adrenergic Blockade on Hypoglycaemic Effect of Glucagon-like Peptide-1 (GLP-1) in Normal Subjects. Diabetic Medicine. 13(6). 544–548. 7 indexed citations
5.
Madsbad, Sten, et al.. (1996). [Clinical consequences of intranasal insulin therapy in insulin-dependent diabetes mellitus].. PubMed. 158(24). 3451–5. 1 indexed citations
6.
Hilsted, J., Sten Madsbad, A. Hvidberg, et al.. (1995). Intranasal insulin therapy: the clinical realities. Diabetologia. 38(6). 680–684. 2 indexed citations
7.
Hilsted, J., Sten Madsbad, A. Hvidberg, et al.. (1995). Intranasal insulin therapy: the clinical realities. Diabetologia. 38(6). 680–684. 53 indexed citations
8.
Rasmussen, Michael Højby, A. Hvidberg, Anders Juul, et al.. (1995). Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.. The Journal of Clinical Endocrinology & Metabolism. 80(4). 1407–1415. 207 indexed citations
9.
Hvidberg, A., R. Djurup, & J. Hilsted. (1994). Glucose recovery after intranasal glucagon during hypoglycaemia in man. European Journal of Clinical Pharmacology. 46(1). 15–7. 16 indexed citations
10.
Holst, Jens J., M Bersani, A. Hvidberg, et al.. (1993). On the effects of human galanin in man. Diabetologia. 36(7). 653–657. 32 indexed citations
11.
Hvidberg, A., Finn Stener Jørgensen, & J. Hilsted. (1992). The effect of genetically engineered glucagon on glucose recovery after hypoglycaemia in man.. British Journal of Clinical Pharmacology. 34(6). 547–550. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026